Substituted phenyl alkylureas as new potent antipsoriatic drugs: Mechanism of action and structure-activity relationships
取代苯基烷基脲作为新型强效抗银屑病药物:作用机制和构效关系
基本信息
- 批准号:323176
- 负责人:
- 金额:$ 45.42万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2015
- 资助国家:加拿大
- 起止时间:2015-03-01 至 2020-03-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Psoriasis is a major health problem affecting up to 3 % of the population. The disease is characterized by an abnormally excessive and rapid growth of the epidermal layer of the skin. Skin cells are replaced every 3 to 5 days in psoriasis rather than the
牛皮癣是一个主要的健康问题,影响到多达3%的人口。这种疾病的特征是皮肤的表皮层异常过度和快速生长。皮肤细胞更换每3至5天在牛皮癣,而不是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
C.-Gaudreault Ren其他文献
C.-Gaudreault Ren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('C.-Gaudreault Ren', 18)}}的其他基金
Validation of Highly Potent Substituted Phenyl Alkylureas as Antipsoriatic Agents
高效取代苯基烷基脲作为抗银屑病药物的验证
- 批准号:
370886 - 财政年份:2017
- 资助金额:
$ 45.42万 - 项目类别:
Operating Grants
Optimization and Validation of Highly Cytocidal Substituted Phenyl Imidazolidin-2-one as Antimicrotubule Agents for Cancer Chemotherapy
高杀伤细胞取代苯基咪唑烷-2-酮作为癌症化疗抗微管剂的优化和验证
- 批准号:
227974 - 财政年份:2011
- 资助金额:
$ 45.42万 - 项目类别:
Operating Grants
相似海外基金
Investigations into the antibacterial mechanism of action of cannabidiol
大麻二酚抗菌作用机制的研究
- 批准号:
DP240102291 - 财政年份:2024
- 资助金额:
$ 45.42万 - 项目类别:
Discovery Projects
Investigation of Mergo? mechanism of action by quantitative serum protein profiling.
调查梅尔戈?
- 批准号:
10074412 - 财政年份:2023
- 资助金额:
$ 45.42万 - 项目类别:
Collaborative R&D
MICA: Deciphering the mechanism of action of miR-125b in beta cells and its therapeutic potential in Diabetes
MICA:破译 miR-125b 在 β 细胞中的作用机制及其治疗糖尿病的潜力
- 批准号:
MR/X009912/1 - 财政年份:2023
- 资助金额:
$ 45.42万 - 项目类别:
Research Grant
Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
- 批准号:
10653587 - 财政年份:2023
- 资助金额:
$ 45.42万 - 项目类别:
Mechanism of action of Dapsone in Mycobacterium leprae
氨苯砜对麻风分枝杆菌的作用机制
- 批准号:
10643361 - 财政年份:2023
- 资助金额:
$ 45.42万 - 项目类别:
The interaction between anamorelin and immune checkpoint inhibitors and its mechanism of action
阿拉莫林与免疫检查点抑制剂的相互作用及其作用机制
- 批准号:
23K07600 - 财政年份:2023
- 资助金额:
$ 45.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the role and mechanism of action of prostaglandin E2 in cancer though the immune suppression activity of Treg cells
通过Treg细胞的免疫抑制活性阐明前列腺素E2在癌症中的作用和作用机制
- 批准号:
23K06356 - 财政年份:2023
- 资助金额:
$ 45.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding the mechanism of action for anticancer sulfonamides that target splicing
了解靶向剪接的抗癌磺胺类药物的作用机制
- 批准号:
10442262 - 财政年份:2023
- 资助金额:
$ 45.42万 - 项目类别:
Reducing antimicrobial resistant bacteria with the use of cold atmospheric plasma: Mechanism of action and influence on mutation and horizontal gene t
使用冷大气等离子体减少抗菌药物耐药性细菌:作用机制以及对突变和水平基因t的影响
- 批准号:
2888329 - 财政年份:2023
- 资助金额:
$ 45.42万 - 项目类别:
Studentship
Characterization of JT-4-173, a Potent Antiviral that Inhibits HIV-1 by a Novel Mechanism of Action
JT-4-173 的表征,一种通过新颖作用机制抑制 HIV-1 的强效抗病毒药物
- 批准号:
10762518 - 财政年份:2023
- 资助金额:
$ 45.42万 - 项目类别: